These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1250664)

  • 1. Generic prescribing.
    Pediatrics; 1976 Feb; 57(2):275-7. PubMed ID: 1250664
    [No Abstract]   [Full Text] [Related]  

  • 2. Physician-controlled source selection--a suggested approach to substitution.
    Chadwick BM
    J Leg Med (N Y); 1976 Mar; 4(3):27-32. PubMed ID: 1083406
    [No Abstract]   [Full Text] [Related]  

  • 3. American Academy of Pediatrics Committee on Drugs: Generic prescribing, generic substitution, and therapeutic substitution.
    Pediatrics; 1987 May; 79(5):835. PubMed ID: 3575043
    [No Abstract]   [Full Text] [Related]  

  • 4. Benefits and liabilities of generic prescribing.
    Lee AM
    W V Med J; 1972 Jun; 68(6):161-6. PubMed ID: 4504384
    [No Abstract]   [Full Text] [Related]  

  • 5. Prescriptions enter the political arena.
    Regier H
    J Leg Med (N Y); 1974; 2(2):24-30. PubMed ID: 4545342
    [No Abstract]   [Full Text] [Related]  

  • 6. The importance of bioavailability to the pharmacist.
    Canada AT
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):346-8. PubMed ID: 1158541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter: Antisubstitution vs. cooperative substitution.
    Jones ME; Helling DK; Widmer RB
    Am Fam Physician; 1976 Jul; 14(1):27. PubMed ID: 937160
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biopharmaceutics, biodisposibility, bioequivalency].
    Cingolani E
    Ann Ist Super Sanita; 1982; 18(3):531-2. PubMed ID: 7187840
    [No Abstract]   [Full Text] [Related]  

  • 9. Genesis of generic drugs.
    Calesnick B; Kreider LA; Dinan A
    Pa Med; 1986 Dec; 89(12):32, 34, 36. PubMed ID: 3808720
    [No Abstract]   [Full Text] [Related]  

  • 10. Trade names or approved names. Part IV. The solution. Prescribing and the regulation of formulation.
    Beckett AH
    Postgrad Med J; 1974 Feb; 50(580):125-9. PubMed ID: 4465774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brand versus generic prescribing: a perspective of the Indian cardiologists' viewpoint.
    Bansinath M; Sequeira RP; Shukla VK; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):279-83. PubMed ID: 6746151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and generic prescribing.
    Mindel JS
    Surv Ophthalmol; 1976; 21(3):262-75. PubMed ID: 13505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generic drug study response gratifying.
    Starr JE
    Ohio Med; 1990 May; 86(5):338-9. PubMed ID: 2140151
    [No Abstract]   [Full Text] [Related]  

  • 14. The potential clinical significance of differences in bioavailability.
    Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
    [No Abstract]   [Full Text] [Related]  

  • 15. For and against generic prescribing.
    Drug Ther Bull; 1987 Nov; 25(24):93-5. PubMed ID: 3428170
    [No Abstract]   [Full Text] [Related]  

  • 16. Generic drugs: an overview.
    Helgeland D
    S D Med; 2006 Apr; 59(4):161-3. PubMed ID: 16681165
    [No Abstract]   [Full Text] [Related]  

  • 17. Panel discussion: practical importance of generic equivalence.
    Ann Clin Res; 1974; 6(0):suppl 11:79-88. PubMed ID: 4212521
    [No Abstract]   [Full Text] [Related]  

  • 18. Patients' attitudes to generic prescribing.
    McAdam NW
    J R Coll Gen Pract; 1986 Jun; 36(287):288. PubMed ID: 3761254
    [No Abstract]   [Full Text] [Related]  

  • 19. Two U.S. agencies offer generic drug law.
    Fisher MJ
    Natl Underwrit Life Health; 1979 Jan; 83(2):2, 7. PubMed ID: 10239881
    [No Abstract]   [Full Text] [Related]  

  • 20. Society testifies on bioavailability, bioequivalence.
    Hayes AH
    Pa Med; 1975 Sep; 78(9):59-60. PubMed ID: 1178207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.